HanchorBio's Listing on TPEx Enhances the Reach of HCB101 Immunotherapy HanchorBio Inc. is now listed on Taiwan's TPEx, enhancing its global presence. The company aims to revolutionize cancer treatment with its innovative HCB101 immunotherapy.

HanchorBio's Listing on TPEx Enhances the Reach of HCB101 Immunotherapy #Taiwan #Taipei #HanchorBio #HCB101 #Taipei_Exchange